Jay Pepose - 07 Jun 2021 Form 4 Insider Report for Ocuphire Pharma, Inc. (IRD)

Role
Director
Signature
/s/ Emily J. Johns, by Power of Attorney
Issuer symbol
IRD
Transactions as of
07 Jun 2021
Net transactions value
$0
Form type
4
Filing time
09 Jun 2021, 18:21:48 UTC
Next filing
15 Sep 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCUP Stock Option (right to buy) Award $0 +40,000 $0.000000 40,000 07 Jun 2021 Common Stock 40,000 $5.74 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Will vest in a series of three successive equal annual installments over the three-year period measured from the date of grant, subject to the Reporting Person's continuing service through each applicable vesting date.